FDA Office of Generic Drugs
This article was originally published in The Tan Sheet
Executive Summary
Cardio-Renal Drug Products Supervisory Management Officer Gary Buehler will join OGD as deputy director May 1. Buehler previously served as acting chief of the project management staff and chair of the medication errors committee, which was dissolved in December with the establishment of the Office of Post-marketing Drug Risk Assessment. He succeeds Gordon Johnston, who departed in January